Pulmonx (LUNG) Cash from Operations (2019 - 2025)

Pulmonx (LUNG) has 7 years of Cash from Operations data on file, last reported at 8192000.0 in Q3 2025.

• Cash from Operations for Q3 2025 came in at 8192000.0, down 13.78% year-over-year; the trailing twelve-month figure through Sep 2025 was 32029000.0 (up 3.53% YoY), and the FY2024 annual result was 31537000.0, up 16.12% from the prior year.
• Cash from Operations eased to 8192000.0 in Q3 2025 per LUNG's latest filing, from 3900000.0 in the prior quarter.
• Over five years, Cash from Operations peaked at 3900000.0 in Q2 2025 and troughed at 15026000.0 in Q1 2022.
• A 5-year average of 9521684.21 and a median of 9564000.0 in 2022 frame the typical range for Cash from Operations.
• The sharpest annual moves came in 2021 and 2025: Cash from Operations plunged 64.94% in 2021, then surged 32.82% in 2025.
• A 5-year view of Cash from Operations shows it stood at 10700000.0 in 2021, then increased by 8.36% to 9806000.0 in 2022, then grew by 14.34% to 8400000.0 in 2023, then grew by 19.8% to 6737000.0 in 2024, then declined by 21.6% to 8192000.0 in 2025.
• Business Quant data shows LUNG's Cash from Operations at 8192000.0 in Q3 2025, 3900000.0 in Q2 2025, and 13200000.0 in Q1 2025.